Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Irinotecan Injection Concentrate
Active Ingredient: Irinotecan hydrochloride 20mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Mayne Pharma Pty Limited
Manufacturer: Mayne Pharma Pty Limited, Mulgrave North, Victoria, Australia
Product: Lorfast
Active Ingredient: Loratadine 10mg
Dosage Form: Tablet
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cadila Pharmaceuticals Limited, Dholka, District Ahmedabad, Gujarat State, India
Dated this 11th day of July 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).